137 related articles for article (PubMed ID: 35526388)
21. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
22. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
Delisle BP; Slind JK; Kilby JA; Anderson CL; Anson BD; Balijepalli RC; Tester DJ; Ackerman MJ; Kamp TJ; January CT
Mol Pharmacol; 2005 Jul; 68(1):233-40. PubMed ID: 15851652
[TBL] [Abstract][Full Text] [Related]
23. Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.
Platonov PG; McNitt S; Polonsky B; Rosero SZ; Kutyifa V; Huang A; Moss AJ; Zareba W
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e005918. PubMed ID: 30012873
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2.
Gu K; Qian D; Qin H; Cui C; Fernando WCHA; Wang D; Wang J; Cao K; Chen M
Pflugers Arch; 2021 Feb; 473(2):219-229. PubMed ID: 33449212
[TBL] [Abstract][Full Text] [Related]
26. Suppression and Replacement Gene Therapy for
Bains S; Zhou W; Dotzler SM; Martinez K; Kim CJ; Tester DJ; Ye D; Ackerman MJ
Circ Genom Precis Med; 2022 Dec; 15(6):e003719. PubMed ID: 36252106
[TBL] [Abstract][Full Text] [Related]
27. ANK2 functionally interacts with KCNH2 aggravating long QT syndrome in a double mutation carrier.
Gessner G; Runge S; Koenen M; Heinemann SH; Koenen M; Haas J; Meder B; Thomas D; Katus HA; Schweizer PA
Biochem Biophys Res Commun; 2019 May; 512(4):845-851. PubMed ID: 30929919
[TBL] [Abstract][Full Text] [Related]
28. The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom.
Okata S; Yuasa S; Yamane T; Furukawa T; Fukuda K
J Med Dent Sci; 2013 Mar; 60(1):17-22. PubMed ID: 23917959
[TBL] [Abstract][Full Text] [Related]
29. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign.
Mattivi CL; Ye D; Tester DJ; Clemens DJ; Zhou W; Giudicessi JR; Ackerman MJ
Heart Rhythm; 2020 Feb; 17(2):315-323. PubMed ID: 31493592
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
[TBL] [Abstract][Full Text] [Related]
31. Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome.
De Zio R; Gerbino A; Forleo C; Pepe M; Milano S; Favale S; Procino G; Svelto M; Carmosino M
J Cell Mol Med; 2019 Sep; 23(9):6331-6342. PubMed ID: 31361068
[TBL] [Abstract][Full Text] [Related]
32. Nonsense-Mediated mRNA Decay of hERG Mutations in Long QT Syndrome.
Gong Q; Zhou Z
Methods Mol Biol; 2018; 1684():37-49. PubMed ID: 29058182
[TBL] [Abstract][Full Text] [Related]
33. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
34. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
Bellin M; Casini S; Davis RP; D'Aniello C; Haas J; Ward-van Oostwaard D; Tertoolen LG; Jung CB; Elliott DA; Welling A; Laugwitz KL; Moretti A; Mummery CL
EMBO J; 2013 Dec; 32(24):3161-75. PubMed ID: 24213244
[TBL] [Abstract][Full Text] [Related]
35. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K
Kozek KA; Glazer AM; Ng CA; Blackwell D; Egly CL; Vanags LR; Blair M; Mitchell D; Matreyek KA; Fowler DM; Knollmann BC; Vandenberg JI; Roden DM; Kroncke BM
Heart Rhythm; 2020 Dec; 17(12):2180-2189. PubMed ID: 32522694
[TBL] [Abstract][Full Text] [Related]
36. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
[TBL] [Abstract][Full Text] [Related]
37. hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation.
Chang Y; Li YN; Bai R; Wu F; Ma S; Saleem A; Zhang S; Jiang Y; Dong T; Guo T; Hang C; Lu WJ; Jiang H; Lan F
Stem Cell Res Ther; 2021 May; 12(1):278. PubMed ID: 33962658
[TBL] [Abstract][Full Text] [Related]
38. Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias.
Brandão KO; van den Brink L; Miller DC; Grandela C; van Meer BJ; Mol MPH; de Korte T; Tertoolen LGJ; Mummery CL; Sala L; Verkerk AO; Davis RP
Stem Cell Reports; 2020 Nov; 15(5):1127-1139. PubMed ID: 33176122
[TBL] [Abstract][Full Text] [Related]
39. A Novel
Cheng YW; Wu CT; Chang CJ; Yeh YH; Chang GJ; Tsai HY; Hsu LA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628921
[No Abstract] [Full Text] [Related]
40. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K
Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
